CJC-1295 DAC human research

Use the original source to resolve the exact long-acting molecule before interpreting findings. Search matches do not establish formulation identity.

Read with these questions in mind

Do not transfer long-acting CJC-1295 findings to no-DAC / Mod GRF 1-29.
Distinguish hormone exposure measurements from functional outcomes.
Check whether the abstract provides actual amounts or only ascending-dose descriptions.

Selected from the completed-summary collection, not a systematic review or exhaustive literature search. Human reports appear first; reviews and preclinical work retain their labels.

Search, filter and compare →

Human · 2005-12-13

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.

Two randomized, double-blind trials compared long-acting CJC-1295 with placebo, measuring growth hormone, IGF-I and drug-processing characteristics.

No author-stated limitations were available in the abstract. The reported endpoints were hormone levels and pharmacokinetics, not demonstrated muscle gain or recovery benefits.